U.S. halts $500mn in funding for mRNA vaccine projects
LOS ANGELES, Aug. 5 (Xinhua) -- The United States is halting hundreds of millions of dollars in funding for the development of mRNA-based vaccines as part Kenya breaking news | Kenya news today |..
✨ Key Highlights
The United States has announced a significant policy shift in its federal public health strategy, halting $500 million in funding for mRNA vaccine projects. This decision, announced by the Department of Health and Human Services (HHS), signals a move towards what it deems "safer, broader vaccine platforms."
- Affected projects amounted to nearly $500 million in funding.
- HHS Secretary Robert F. Kennedy Jr. stated the decision was based on data indicating mRNA vaccines "fail to protect effectively against upper respiratory infections like Covid and and flu."
- The HHS will now prioritize technologies with stronger safety records and greater transparency in clinical and manufacturing data.
Continue Reading
Read the complete article from Capital Business
Part of the Day's Coverage
International Legal and Funding Actions Against Corporations and Projects - August 2025
Approximately 30 Lithuanian hotels have joined a class action lawsuit against Booking.com, part of a larger legal action involving over 10,000 European hotels seeking compensation for alleged losses from Booking.com’s 'best price' clause. Concurrently, the United States has halted $500 million in funding for mRNA vaccine projects, shifting its federal public health strategy to 'safer, broader vaccine platforms'. In another development, two Chinese nationals, Chuan Geng and Shiwei Yang, face charges for allegedly orchestrating an illegal scheme to export millions of dollars' worth of Nvidia AI chips from the US to China.
